Mucositis: biology and management.

Area of Science:

• Oncology
• Radiation Oncology
• Cancer Therapeutics

Background:

• Oral mucositis is a frequent, dose-limiting toxicity in head and neck cancer treatment.
• It negatively affects patient morbidity, treatment compliance, and overall outcomes.
• Current management focuses on minimizing radiation exposure and providing symptomatic relief.

Purpose of the Study:

• To review recent advancements in understanding and managing oral mucositis.
• To explore novel, biologically-based preventive treatments for chemoradiation-induced mucosal injury.
• To consider the impact of modern radiation therapy techniques.

Main Methods:

• Review of recent scientific literature on oral mucositis.
• Analysis of biological and cellular mechanisms of chemoradiation-induced mucosal injury.
• Evaluation of emerging therapeutic agents and treatment planning advancements.

Main Results:

• Chemoradiation-induced mucosal injury involves complex biological events primarily in the submucosa.
• Novel preventive treatments are under development and in clinical trials.
• Advancements in radiation therapy planning and delivery are being considered.

Conclusions:

• Oral mucositis is a serious complication of head and neck cancer chemoradiotherapy.
• Existing interventions offer limited efficacy, necessitating new approaches.
• Future treatments promise to reduce the severity and duration of oral mucositis.